Predicting protein phase separation
St. Jude has developed a way to predict how proteins phase separate. The answer will help scientists studying how these proteins contribute to disease.
St. Jude Children’s Research Hospital president and CEO honored for contributions to pediatric cancer research
James R. Downing, M.D., receives inaugural award from prestigious cancer research association.
Douglas R. Green, Ph.D., of St. Jude elected to the National Academy of Sciences
St. Jude Children’s Research Hospital immunologist recognized for his contribution to understanding the mechanism of cell death and survival.
Expanding ways to tame a global childhood killer
A new anti-malarial drug offers hope for children suffering from Malaria.
Significant global investment could save 11 million children
A report shows an investment in treating children with cancer could save 11 million lives and produce a triple return on investment to the global economy.
Inherited mutation can drive SHH medulloblastoma
Researchers find connections to inherited genetic mutations to a type of brain tumor. The study suggests certain genes should be included in routine testing.
Combination therapy holds promise for rare immune disorder
Recent research shows how an overactive immune system produces too many cytokines in HLH.
From Promise, Autumn 2020